ResMed Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -4.7% | +47.4% | +9.5% | -26.0% | -5.2% | +87.5% | -6.9% | -15.1% | -25.7% | +63.1% | +225.9% | – | |
| – | -0.1% | +2.4% | +0.2% | -1.9% | +4.1% | -7.1% | +43.1% | -22.4% | +8.1% | +10.8% | -20.2% | – | |
| – | +7.2% | +3.0% | +4.6% | -5.8% | +12.3% | +6.6% | +2.6% | -14.5% | +36.8% | -7.4% | +289.5% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | +40.0% | -204.0% | – | +122.7% | -92.7% | +161.2% | -663.4% | – | -163.4% | – | |
| – | -42.9% | -1.0% | +13.9% | -25.5% | -3.7% | +26.0% | +28.6% | +40.5% | -19.6% | -2.6% | +364.4% | – | |
| – | -72.4% | -19.4% | +40.3% | – | -1,809.8% | -13.4% | +320.7% | -60.7% | -3.1% | +13.9% | +839.5% | – | |
| – | +0.1% | -0.3% | +0.1% | +10.4% | -0.3% | +0.0% | -0.1% | +13.1% | -0.2% | -0.4% | +300.8% | – | |
| – | -147.6% | 0.0% | +0.0% | +0.0% | +50.0% | +0.1% | +33.3% | +50.0% | +16.7% | 0.0% | +300.0% | – | |
| – | – | – | – | – | -83.3% | -100.0% | – | -100.0% | – | -100.0% | – | – | |
| – | +58.1% | +40.6% | +17.1% | -61.7% | -2.1% | -2.3% | +13.8% | +40.5% | +12.2% | -1.2% | +294.5% | – | |
| – | – | +2,311.8% | -98.4% | +41,585.1% | -49.2% | +329.7% | -32.6% | -37.0% | -81.0% | +632.8% | +6.7% | – | |
| – | +1.7% | +51.9% | +9.2% | -26.1% | -5.3% | +91.5% | -8.4% | -18.5% | -26.3% | +70.5% | +216.9% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.